Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

Sep 29, 2020
|
staff reporter

NEW YORK —  Oxford Immunotec said on Tuesday that it has received clearance from the US Food and Drug Administration to amend the pediatric age limitation for its T-Spot.TB tuberculosis (TB) test to include individuals two years of age and older.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Infectious Disease

  1. Roche Continues Expanding Diagnostic Portfolio for SARS-CoV-2 and Beyond

    Premium

  2. Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

  3. FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

  4. A. Menarini Diagnostics SARS-CoV-2 Test Can Determine High, Low Viral Loads, Company Says

    Premium

  5. CMS Changes Reimbursement Rates to Accelerate COVID-19 Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.